[ad_1] WASHINGTON (Reuters) – U.S. consumers cut spending by the most on record for the second straight month in April while boosting savings to an all-time high, and the growing frugality reinforced expectations the economy
[ad_1] European and South Korean authorities are vying for Gilead Sciences’ potential COVID-19 treatment, remdesivir, even though the drugmaker has yet to gain regulatory approval in either market and is still ramping up production of
[ad_1] FILE PHOTO: Grindr app is seen on a mobile phone in this photo illustration taken in Shanghai, China March 28, 2019. REUTERS/Aly Song/Illustration (Reuters) – Chinese gaming company Beijing Kunlun Tech Co Ltd said
[ad_1] FILE PHOTO: The logo of Sanofi is seen at the company’s headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau PARIS (Reuters) – Sanofi has temporarily stopped recruiting new COVID-19 patients for its two
[ad_1] WASHINGTON (Reuters) – U.S. consumers cut spending by the most on record for the second straight month in April while boosting savings to an all-time high, and the growing frugality reinforced expectations the economy
[ad_1] BUENOS AIRES (Reuters) – Shallow water in Argentina’s Parana River will slow exports and hurt the country’s soy crushing margins at least through September, officials said, as more cargo ships are needed to carry
[ad_1] Traders walk past the New York Stock Exchange as the building opens for the first time since March while the outbreak of the coronavirus disease (COVID19) continues in the Manhattan borough of New York,
[ad_1] BENGALURU (Reuters) – India’s economy grew 3.1% in the January-March quarter compared with the same period last year, the slowest growth in at least eight years, official data showed on Friday, reflecting the partial
[ad_1] (Reuters) – Oil prices will gradually gain this year with demand improving and supply falling, although tensions between the United States and China are hanging over the coronavirus-hit market, a Reuters poll showed on
[ad_1] A guard walks inside the office of Sun Pharmaceutical Industries Ltd in Mumbai, November 13, 2018. REUTERS/Francis Mascarenhas/Files BENGALURU (Reuters) – Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory
HubTrades is authorized by The Financial Commission, an independent external dispute resolution (EDR) organization, allowing the company and its customers a wide range of services and membership benefits including customer protection in case of disputes, up to €20,000 per case.our customers are insured for the safety of funds.
HubTrades Capital Co., Limited is regulated by the Financial Market Conduct Authority (FSA) of St. Vincent and the Grenadines of the Commonwealth of Nations. The FSA regulatory number is 26737 IBC.
RISK WARNING:
Trading Foreign Exchange and Contracts for Difference (CFDs) is highly speculative and may not be suitable for all investors. HubTrades offers trading on margin. The leverage created by trading on margin can work against you as well as for you. Losses can exceed your entire investment. Only invest with money you can afford to lose and ensure that you fully understand the risks involved. Please ensure you read our Risk Disclosure and Terms and Conditions in full before opening an account with HubTrades.
Restricted Regions: HubTrades does not provide services for residents of certain countries, such as the United States, North Korea, Myanmar, Cuba, Sudan, Syria and some other regions.
Google PlayStore and Apple AppStore are the property of their respective trademark holders.